Stock screenerAll disclosures →
EDGAR →
LGVN
Conviction 34HealthcareScan · Fri, Jun 26, 2026Three black crows
LGVN$0.7164-1.73%
ResistanceSupportVol 14Vol MA14 248.62K
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price0.7164
Change-1.73%
Gap+0.15%
Rel volume4.74×
Avg volume248.59K
Avg $ vol190.74K
SMA 200.7744
SMA 500.8214
SMA 2000.7458
Price vs 50-12.78%
Price vs 200-3.94%
MA stackmixed
50/200 cross—
Supertrenddown · 0.8403
RSI (14)39
MACD hist-0.00
MACD crossbear · 0d
Stoch %K / %D10 / 10
ADX (14)14
+DI / −DI14 / 22
RSI divergence—
MACD divergenceBearish
ATR %+8.13%
ADR %6.91%
52w high1.74
52w low0.4836
From 52w high-58.83%
Above 52w low+48.14%
New 52w highNo
SqueezeOn · 8d
Bollinger width15.76%
%B0.02
Donchian pos10.10%
Donchian high0.8650
Donchian low0.6997
AVWAP (52w high)0.8780
vs AVWAP high-18.41%
AVWAP (52w low)0.9025
vs AVWAP low-20.62%
OBV trendDown
Chaikin MF (20)-0.35
Today vs 20d4.74×
Avg vol (14d)248.62K
Avg vol (20d)248.59K
Avg $ vol (20d)190.74K
Market cap—
RS 3m (vs SPY)-36.88%
RS 6m (vs SPY)+27.68%
RS line new highNo
Trend template1/8
Technical rank40.4
1 week-12.64%
1 month-9.88%
3 months-26.36%
6 months+32.42%
1 year-43.59%
YTD+20.81%
P/E-557.47
P/B789.72
P/S—
P/FCF-670.03
EPS-1.29
Div yield—
ROE-141.66%
ROA-107.04%
Debt/Eq0.01
Current3.88
EV/EBITDA-562.16
Gross margin66.97%
Net margin—
Rev growth-49.87%
EPS growth-42.14%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value12.64B
Revenue398K
Net income-4.74M
Gross profit264K
Free cash flow-18.89M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out30.15M
Employees38
ListedFri, Feb 12, 2021
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction34 / 100
Pattern quality—
Tech rank40.4 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree black crows
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in LGVN
No recent disclosed trades by Congress in LGVN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in LGVN · 5 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Blass Devin CTO & SVP of CMC · Class A Common Stock · 2026-05-01 | Grant | 250K | $0 | 2026-05-01 | 2026-05-05 |
Agafonova Nataliya Chief Medical Officer · Class A Common Stock · 2026-05-01 | Grant | 250K | $0 | 2026-05-01 | 2026-05-05 |
Locklear Lisa Chief Financial Officer · Class A Common Stock · 2026-05-01 | Grant | 250K | $0 | 2026-05-01 | 2026-05-05 |
Willard Stephen H Chief Executive Officer · Class A Common Stock · 2026-05-01 | Grant | 500K | $0 | 2026-05-01 | 2026-05-05 |
Lehr Paul T General Counsel, Secretary · Class A Common Stock · 2026-05-01 | Grant | 250K | $0 | 2026-05-01 | 2026-05-05 |
SEC filings
EDGAR filings in LGVN · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.